Physiological Microenvironment Dependent Self-Cross-Linking of Multifunctional Nanohybrid for Prolonged Antibacterial Therapy via Synergistic Chemodynamic-Photothermal-Biological Processes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38829311.
- Also identified by DOI 10.1021/acs.nanolett.4c00671.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Herein, a multifunctional nanohybrid (PL@HPF<sub>TM</sub> nanoparticles) was fabricated to perform the integration of chemodynamic therapy, photothermal therapy, and biological therapy over the long term at a designed location for continuous antibacterial applications. The PL@HPF<sub>TM</sub> nanoparticles consisted of a polydopamine/hemoglobin/Fe<sup>2+</sup> nanocomplex with comodification of tetrazole/alkene groups on the surface as well as coloading of antimicrobial peptides and luminol in the core. During therapy, the PL@HPF<sub>TM</sub> nanoparticles would selectively cross-link to surrounding bacteria via tetrazole/alkene cycloaddition under chemiluminescence produced by the reaction between luminol and overexpressed H<sub>2</sub>O<sub>2</sub> at the infected area. The resulting PL@HPF<sub>TM</sub> network not only significantly damaged bacteria by Fe<sup>2+</sup>-catalyzed ROS production, effective photothermal conversion, and sustained release of antimicrobial peptides but dramatically enhanced the retention time of these therapeutic agents for prolonged antibacterial therapy. Both <i>in vitro</i> and <i>in vivo</i> results have shown that our PL@HPF<sub>TM</sub> nanoparticles have much higher bactericidal efficiency and remarkably longer periods of validity than free antibacterial nanoparticles.
Medical subject headings
- Anti-Bacterial Agents
- Nanoparticles